K
KLOTHO NEUROSCIENCES, INC.
NASDAQ: KLTO (Klotho Neurosciences, Inc.)
Last update: yesterday, 10:49PM0.485
-0.01 (-2.00%)
| Previous Close | 0.495 |
| Open | 0.547 |
| Volume | 15,426,158 |
| Avg. Volume (3M) | 32,838,745 |
| Market Cap | 30,380,358 |
| Price / Book | 2.85 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.270 |
| Total Debt/Equity (MRQ) | 276.80% |
| Current Ratio (MRQ) | 0.290 |
| Operating Cash Flow (TTM) | -4.48 M |
| Levered Free Cash Flow (TTM) | -1.95 M |
| Return on Assets (TTM) | -151.41% |
| Return on Equity (TTM) | -1,544.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Klotho Neurosciences, Inc. | - | - |
AIStockmoo Score
0.2
| Analyst Consensus | 0.0 |
| Insider Activity | 3.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.20 |
|
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 50.23% |
| % Held by Institutions | 2.60% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Banco Btg Pactual S.A. | 30 Jun 2025 | 20,495 |
| Ep Wealth Advisors, Llc | 30 Jun 2025 | 10,000 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| LEBLANC JEFF | 0.754 | - | 200,000 | 150,800 |
| Aggregate Net Quantity | 200,000 | |||
| Aggregate Net Value ($) | 150,800 | |||
| Aggregate Avg. Buy ($) | 0.754 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LEBLANC JEFF | Officer | 25 Aug 2025 | Acquired (+) | 200,000 | 0.754 | 150,800 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |